McAdam, LLC

Position in DFTX — Definium Therapeutics, Inc.

CIK 1695490 Philadelphia, PA

Position in DFTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$323,588

New position

Shares Held

6,879

first reported quarter

Ownership

0.005%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#246

of 358 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

McAdam, LLC holds $891,103 across 5 Biotechnology names. DFTX ranks #1 (36.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc. This page	6,879	$323,588
2	VRTX	Vertex Pharmaceuticals Inc / Ma	543	$269,724
3	IBRX	ImmunityBio, Inc.	21,409	$187,435
4	CGTX	Cognition Therapeutics Inc	64,553	$74,235
5	CMPX	Compass Therapeutics, Inc.	16,494	$36,121

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$323,588	6,879	—	Shares	Sole	2026-08-04
No filing history on record for this holder in this stock.